BridgeBio Pharma Inc (NASDAQ:BBIO)
| 14.24 Delayed Data As of Jun 02 |  +0.24 / +1.71%Today’s Change | 5.74 Today|||52-Week Range 19.95 | +86.88% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Kumar Neil /bridgebio/ President & Chief Executive Officer |  Sale | 4/05/2023 | 120,000 | $15.46 | $1.9M | -8.18% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 5/03/2023 | 120,000 | $14.18 | $1.7M | -0.97% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 2/03/2023 | 120,000 | $11.01 | $1.3M | +31.31% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 3/03/2023 | 120,000 | $10.96 | $1.3M | +31.19% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 5/03/2023 | 64,929 | $14.18 | $920.7K | -0.97% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 1/05/2023 | 120,000 | $7.67 | $920.4K | +85.68% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 4/05/2023 | 55,500 | $15.45 | $857.5K | -8.18% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 5/17/2023 | 51,552 | $14.01 | $722.2K | +1.28% |
Kumar Neil /bridgebio/ President & Chief Executive Officer | Sale | 5/16/2023 | 50,697 | $14.09 | $714.3K | +1.21% |
Stephenson Brian C Chief Financial Officer & Secretary | Sale | 3/03/2023 | 62,692 | $10.96 | $687.1K | +31.19% |
Page of 4